INTRODUCTION: Choroid plexus (CP)-related mechanisms have been implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease. In this pilot study, we aimed to elucidate the association between longitudinal changes in CP volume, sex and cognitive impairment. METHODS: We assessed longitudinal changes in CP volume in a cohort of n = 613 subjects across n = 2,334 datapoints from ADNI 2 and ADNI-GO, belonging to cognitively unimpaired (CN), stable mild cognitive impairment (MCI), clinically diagnosed Alzheimer's disease dementia (AD) or convertor (to either AD or MCI) subgroups. CP volume was automatically segmented and used as a response variable in linear mixed effect models with random intercept clustered by patient identity. Temporal effects of select variables were assessed by interactions and subgroup analyses. RESULTS: We found an overall significant increase of CP volume in time (14.92 mm3 per year, 95% confidence interval, CI (11.05, 18.77), p < 0.001). Sex-disaggregated results showed an annual rate of increase 9.48 mm3 in males [95% CI (4.08, 14.87), p < 0.001], and 20.43 mm3 in females [95% CI (14.91, 25.93), p < 0.001], indicating more than double the rate of increase in females, which appeared independent of other temporal variables. The only diagnostic group with a significant CP increase as compared to CN was the convertors group, with an increase of 24.88 mm3/year [95% CI (14, 35.82), p < 0.001]. ApoE exhibited a significant temporal effect, with the E4 homozygote group's CP increasing at more than triple the rate of non-carrier or heterozygote groups [40.72, 95% CI (25.97, 55.46), p < 0.001 vs. 12.52, 95% CI (8.02, 17.02), p < 0.001 for ApoE E4 homozygotes and E4 non-carriers, respectively], and may have modified the diagnostic group relationship. CONCLUSION: Our results contribute to potential mechanisms for sex differences in cognitive impairment with a novel finding of twice the annual choroid plexus enlargement in females and provide putative support for CP-related mechanisms of cognitive deterioration and its relationship to ApoE E4.

Center for Alzheimer Research Division of Clinical Geriatrics Department of Neurobiology Care Sciences and Society Karolinska Institutet Huddinge Sweden

Cognitive Center Department of Neurology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Women's Brain Project Gunterhausen Switzerland

Zobrazit více v PubMed

Damkier HH, Brown PD, Praetorius J. Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev. (2013) 93:1847–92. doi: 10.1152/physrev.00004.2013 PubMed DOI

Silva-Vargas V, Maldonado-Soto AR, Mizrak D, Codega P, Doetsch F. Age-dependent niche signals from the choroid plexus regulate adult neural stem cells. Cell Stem Cell. (2016) 19:643–52. doi: 10.1016/j.stem.2016.06.013 PubMed DOI

Mazucanti CH, Liu QR, Lang D, Huang N, O’Connell JF, Camandola S, et al. . Release of insulin produced by the choroid plexis is regulated by serotonergic signaling. JCI Insight. (2019) 4. doi: 10.1172/jci.insight.131682, PMID: PubMed DOI PMC

Balusu S, van Wonterghem E, de Rycke R, Raemdonck K, Stremersch S, Gevaert K, et al. . Identification of a novel mechanism of blood–brain communication during peripheral inflammation via choroid plexus-derived extracellular vesicles. EMBO Mol Med. (2016) 8:1162–83. doi: 10.15252/emmm.201606271 PubMed DOI PMC

Strominger I, Elyahu Y, Berner O, Reckhow J, Mittal K, Nemirovsky A, et al. . The choroid plexus functions as a niche for T-cell stimulation within the central nervous system. Front Immunol. (2018) 9:1066. doi: 10.3389/fimmu.2018.01066, PMID: PubMed DOI PMC

Cui J, Shipley FB, Shannon ML, Alturkistani O, Dani N, Webb MD, et al. . Inflammation of the embryonic choroid plexus barrier following maternal immune activation. Dev Cell. (2020) 55:617–628.e6. doi: 10.1016/j.devcel.2020.09.020, PMID: PubMed DOI PMC

Fleischer V, Gonzalez-Escamilla G, Ciolac D, Albrecht P, Küry P, Gruchot J, et al. . Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans. Proc Natl Acad Sci U S A. (2021) 118. doi: 10.1073/pnas.2025000118 PubMed DOI PMC

Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. . Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. (2021) 595:565–71. doi: 10.1038/s41586-021-03710-0 PubMed DOI PMC

Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, et al. . Microglial activation and tau propagate jointly across Braak stages. Nat Med. (2021) 27:1592–9. doi: 10.1038/s41591-021-01456-w PubMed DOI

Baruch K, Deczkowska A, David E, Castellano JM, Miller O, Kertser A, et al. . Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science. (2014) 346:89–93. doi: 10.1126/science.1252945 PubMed DOI PMC

Balusu S, Brkic M, Libert C, Vandenbroucke RE. The choroid plexus-cerebrospinal fluid interface in Alzheimer’s disease: more than just a barrier. Neural Regen Res. (2016) 11:534–7. doi: 10.4103/1673-5374.180372, PMID: PubMed DOI PMC

Brkic M, Balusu S, van Wonterghem E, Gorlé N, Benilova I, Kremer A, et al. . Amyloid β oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases. J Neurosci. (2015) 35:12766–78. doi: 10.1523/JNEUROSCI.0006-15.2015 PubMed DOI PMC

Santos CRAA, Duarte AC, Quintela T, Tomás J, Albuquerque T, Marques F, et al. . The choroid plexus as a sex hormone target: functional implications. Front Neuroendocrinol. (2017) 44:103–21. doi: 10.1016/j.yfrne.2016.12.002 PubMed DOI

Alvira-Botero XM, Carro E. Clearance of amyloid-β peptide across the choroid plexus in Alzheimer’s disease. Curr Aging Sci. (2010) 3:219–29. doi: 10.2174/1874609811003030219 PubMed DOI

González-Marrero I, Giménez-Llort L, Johanson CE, Carmona-Calero EM, Castañeyra-Ruiz L, Brito-Armas JM, et al. . Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer’s disease. Front Cell Neurosci. (2015) 9. doi: 10.3389/fncel.2015.00017 PubMed DOI PMC

Bartolome F, Krzyzanowska A, de la Cueva M, Pascual C, Antequera D, Spuch C, et al. . Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer’s disease. Sci Rep. (2020) 10:1–15. doi: 10.1038/s41598-020-66177-5 PubMed DOI PMC

Duarte AC, Furtado A, Hrynchak MV, Costa AR, Talhada D, Gonçalves I, et al. . Age, sex hormones, and circadian rhythm regulate the expression of amyloid-beta scavengers at the choroid plexus. Int J Mol Sci. (2020) 21:1–12. doi: 10.3390/ijms21186813 PubMed DOI PMC

Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. (2016) 16:626–38. doi: 10.1038/nri.2016.90 PubMed DOI

Guneykaya D, Ivanov A, Hernandez DP, Haage V, Wojtas B, Meyer N, et al. . Transcriptional and translational differences of microglia from male and female brains. Cell Rep. (2018) 24:2773–2783.e6. doi: 10.1016/j.celrep.2018.08.001, PMID: PubMed DOI

Duarte-Guterman P, Albert AY, Barha CK, Galea LAM. On behalf of the Alzheimer’s Disease Neuroimaging Initiative. Sex influences the effects of APOE genotype and Alzheimer’s diagnosis on neuropathology and memory. Psychoneuroendocrinology. (2021) 129:105248. doi: 10.1016/j.psyneuen.2021.105248, PMID: PubMed DOI

Kodama L, Gan L. Do microglial sex differences contribute to sex differences in neurodegenerative diseases? Trends Mol Med. (2019) 25:741–9. doi: 10.1016/j.molmed.2019.05.001, PMID: PubMed DOI PMC

Agostini A, Yuchun D, Li B, Kendall DA, Pardon MC. Sex-specific hippocampal metabolic signatures at the onset of systemic inflammation with lipopolysaccharide in the APPswe/PS1dE9 mouse model of Alzheimer’s disease. Brain Behav Immun. (2020) 83:87–111. doi: 10.1016/j.bbi.2019.09.019 PubMed DOI PMC

Delage C, Rendina DN, Malacon KE, Tremblay MÈ, Bilbo SD. (2021) “Sex differences in microglia as a risk factor for Alzheimer’s disease,” in Sex and Gender Differences in Alzheimer’s Disease: Women’s Brain Project (Academic Press; ), 79–104.

Ferretti MT, Martinkova J, Biskup E, Benke T, Gialdini G, Nedelska Z, et al. . Sex and gender differences in Alzheimer’s disease: current challenges and implications for clinical practice: position paper of the dementia and cognitive disorders panel of the European academy of neurology. Eur J Neurol. (2020) 27:928–43. doi: 10.1111/ene.14174, PMID: PubMed DOI

Alisch JSR, Kiely M, Triebswetter C, Alsameen MH, Gong Z, Khattar N, et al. . Characterization of age-related differences in the human choroid plexus volume, microstructural integrity, and blood perfusion using multiparameter magnetic resonance imaging. Front Aging Neurosci. (2021) 13:734992. doi: 10.3389/fnagi.2021.734992 PubMed DOI PMC

Zhou G, Hotta J, Lehtinen MK, Forss N, Hari R. Enlargement of choroid plexus in complex regional pain syndrome. Sci Rep. (2015) 5:1–5. doi: 10.1038/srep14329 PubMed DOI PMC

Lizano P, Lutz O, Ling G, Lee AM, Eum S, Bishop JR, et al. . Association of choroid plexus enlargement with cognitive, inflammatory, and structural phenotypes across the psychosis spectrum. Am J Psychiatr. (2019) 176:564–72. doi: 10.1176/appi.ajp.2019.18070825, PMID: PubMed DOI PMC

Huang J, Tong J, Zhang P, Zhou Y, Li Y, Tan S, et al. . Elevated salivary kynurenic acid levels related to enlarged choroid plexus and severity of clinical phenotypes in treatment-resistant schizophrenia. Brain Behav Immun. (2022) 106:32–9. doi: 10.1016/j.bbi.2022.08.001, PMID: PubMed DOI

Althubaity N, Schubert J, Martins D, Yousaf T, Nettis MA, Mondelli V, et al. . Choroid plexus enlargement is associated with neuroinflammation and reduction of blood brain barrier permeability in depression. Neuroimage Clin. (2022) 33:102926. doi: 10.1016/j.nicl.2021.102926 PubMed DOI PMC

Egorova N, Gottlieb E, Khlif MS, Spratt NJ, Brodtmann A. Choroid plexus volume after stroke. Int J Stroke. (2019) 14:923–30. doi: 10.1177/1747493019851277, PMID: PubMed DOI

Ricigliano VAGA, Morena E, Colombi A, Tonietto M, Hamzaoui M, Poirion E, et al. . Choroid plexus enlargement in inflammatory multiple sclerosis. Radiology. (2021) 301:166–77. doi: 10.1148/radiol.2021204426 PubMed DOI

Klistorner S, Barnett MH, Parratt J, Yiannikas C, Graham SL, Klistorner A. Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy. Ann Clin Transl Neurol. (2022) 9:1528–37. doi: 10.1002/acn3.51644, PMID: PubMed DOI PMC

Müller J, Sinnecker T, Wendebourg MJ, Schläger R, Kuhle J, Schädelin S, et al. . Choroid plexus volume in multiple sclerosis vs Neuromyelitis Optica Spectrum disorder: a retrospective, cross-sectional analysis. Neurol Neuroimmunol Neuroinflamm. (2022) 9. doi: 10.1212/NXI.0000000000001147 PubMed DOI PMC

Alisch JSR, Egan JM, Bouhrara M. Differences in the choroid plexus volume and microstructure are associated with body adiposity. Front Endocrinol. (2022) 13. doi: 10.3389/fendo.2022.984929 PubMed DOI PMC

Tadayon E, Pascual-Leone A, Press D, Santarnecchi E. Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer’s and Parkinson’s disease. Neurobiol Aging. (2020) 89:108–17. doi: 10.1016/j.neurobiolaging.2020.01.005, PMID: PubMed DOI PMC

Čarna M, Onyango IG, Katina S, Nezvedova M, Jha D, Nedelska Z, et al. . (2021). Pathogenesis of Alzheimer’s disease: Involvement of the choroid plexus. Available at: https://www.medrxiv.org/content/10.1101/2021.07.29.21260696v2 (Accessed October 15, 2022). PubMed DOI PMC

Choi JD, Moon Y, Kim HJ, Yim Y, Lee S, Moon WJ. Choroid plexus volume and permeability at brain MRI within the Alzheimer disease clinical spectrum. Radiology. (2022) 304:635–45. doi: 10.1148/radiol.212400, PMID: PubMed DOI

Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif AM, Spinrad A, et al. . Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer’s disease pathology. Nat Commun. (2015) 6. doi: 10.1038/ncomms8967 PubMed DOI PMC

Pintzka CWS, Hansen TI, Evensmoen HR, Håberg AK. Marked effects of intracranial volume correction methods on sex differences in neuroanatomical structures: a HUNT MRI study. Front Neurosci. (2015) 9:238. doi: 10.3389/fnins.2015.00238 PubMed DOI PMC

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. . The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. (2011) 7:263–9. doi: 10.1016/j.jalz.2011.03.005 PubMed DOI PMC

Alzheimer’s Disease Neuroimaging Initiative (2008). ADNI 2: procedures manual.

Alzheimer’s Disease Neuroimaging Initiative (2008). ADNI enroll: demographics.

Reuter M, Rosas HD, Fischl B. (2012). Longitudinal FreeSurfer for reliable imaging biomarkers. Proceedings of the MICCAI Novel Neuroimaging Biomarkers for Alzheimer’s Disease and Related Disorders Workshop and Challenge (NIBAD’12). 12.

Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. (2002) 33:341–55. doi: 10.1016/S0896-6273(02)00569-X PubMed DOI

Almeida OP, Almeida SA. Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry. (1999) 14:858–65. doi: 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8 PubMed DOI

R Core Team (2020). R: A language and environment for statistical computing. Vienna, Austria.

Bates D, Maechler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. (2015) 67:1–48. doi: 10.18637/jss.v067.i01 DOI

Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Softw. (2017) 82. doi: 10.18637/jss.v082.i13 DOI

Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag; (2016).

Schmid Daners M, Knobloch V, Soellinger M, Boesiger P, Seifert B, Guzzella L, et al. . Age-specific characteristics and coupling of cerebral arterial inflow and cerebrospinal fluid dynamics. PLoS One. (2012) 7:e37502. doi: 10.1371/journal.pone.0037502, PMID: PubMed DOI PMC

Rich-Edwards JW, Kaiser UB, Chen GL, Manson JAE, Goldstein JM. Sex and gender differences research design for basic, clinical, and population studies: essentials for investigators. Endocr Rev. (2018) 39:424–39. doi: 10.1210/er.2017-00246, PMID: PubMed DOI PMC

Gamberger D, Lavrač N, Srivatsa S, Tanzi RE, Doraiswamy PM. Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer’s disease. Sci Rep. (2017) 7:1–12. doi: 10.1038/s41598-017-06624-y PubMed DOI PMC

Tifratene K, Robert P, Metelkina A, Pradier C, Dartigues JF. Progression of mild cognitive impairment to dementia due to AD in clinical settings. Neurol Int. (2015) 85:331–8. doi: 10.1212/WNL.0000000000001788 PubMed DOI

Kodama L, Guzman E, Etchegaray JI, Li Y, Sayed FA, Zhou L, et al. . Microglial microRNAs mediate sex-specific responses to tau pathology. Nat Neurosci. (2020) 23:167–71. doi: 10.1038/s41593-019-0560-7, PMID: PubMed DOI PMC

Duarte-Guterman P, Inkster AM, Albert AY, Barha CK, Robinson WP, Galea LAM. Alzheimer’s disease neuropathology, inflammation and epigenetic age: do sex and APOE matter? J Alzheimers Dis. (2020) 78:627–41. doi: 10.3233/JAD-200982, PMID: PubMed DOI

Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, et al. . The major risk factors for Alzheimer’s disease: age, sex, and genes modulate the microglia response to Aβ plaques. Cell Rep. (2019) 27:1293–1306.e6. doi: 10.1016/j.celrep.2019.03.099, PMID: PubMed DOI PMC

Hirokawa K, Utsuyama M, Hayashi Y, Kitagawa M, Makinodan T, Fulop T. Slower immune system aging in women versus men in the Japanese population. Immun Ageing. (2013) 10. doi: 10.1186/1742-4933-10-19 PubMed DOI PMC

Yalcin A, Ceylan M, Bayraktutan OF. Sonkaya AR, Yuce I. Age and gender related prevalence of intracranial calcifications in CT imaging; data from 12,000 healthy subjects. J Chem Neuroanat. (2016) 78:20–4. doi: 10.1016/j.jchemneu.2016.07.008 PubMed DOI

Goyal MS, Blazey TM, Su Y, Couture LE, Durbin TJ, Bateman RJ, et al. . Persistent metabolic youth in the aging female brain. Proc Natl Acad Sci U S A. (2019) 116:3251–5. doi: 10.1073/pnas.1815917116 PubMed DOI PMC

Engelbrecht HR, Merrill SM, Gladish N, MacIsaac JL, Lin DTS, Ecker S, et al. . Sex differences in epigenetic age in Mediterranean high longevity regions. Front Aging. (2022) 3. doi: 10.3389/fragi.2022.1007098 PubMed DOI PMC

Rubin JB, Lagas JS, Broestl L, Sponagel J, Rockwell N, Rhee G, et al. . Sex differences in cancer mechanisms. Biol Sex Differ. (2020) 11:1–29. doi: 10.1186/s13293-020-00291-x PubMed DOI PMC

Dietrich MO, Spuch C, Antequera D, Rodal I, de Yébenes JG, Molina JA, et al. . Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging. (2008) 29:902–12. doi: 10.1016/j.neurobiolaging.2007.01.008 PubMed DOI

Raha-Chowdhury R, Henderson JW, Raha AA, Vuono R, Bickerton A, Jones E, et al. . Choroid plexus acts as gatekeeper for TREM2, abnormal accumulation of ApoE, and fibrillary tau in Alzheimer’s disease and in down syndrome dementia. J Alzheimers Dis. (2019) 69:91–109. doi: 10.3233/JAD-181179, PMID: PubMed DOI PMC

Shuangshoti S, Netsky MG. Human choroid plexus: morphologic and histochemical alterations with age. Am J Anat. (1970) 128:73–95. doi: 10.1002/aja.1001280107, PMID: PubMed DOI

Barkho BZ, Monuki ES. Proliferation of cultured mouse choroid plexus epithelial cells. PLoS One. (2015) 10:e0121738. doi: 10.1371/journal.pone.0121738, PMID: PubMed DOI PMC

Li Y, Chen J, Chopp M. Cell proliferation and differentiation from ependymal, subependymal and choroid plexus cells in response to stroke in rats. J Neurol Sci. (2002) 193:137–46. doi: 10.1016/S0022-510X(01)00657-8 PubMed DOI

Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, et al. . Comparative transcriptomics of choroid plexus in Alzheimer’s disease, frontotemporal dementia and Huntington’s disease: implications for CSF homeostasis. Fluids Barriers CNS. (2018) 15:18. doi: 10.1186/s12987-018-0102-9 PubMed DOI PMC

Shim JW, Madsen JR. VEGF signaling in neurological disorders. Int J Mol Sci. (2018) 19. doi: 10.3390/ijms19010275, PMID: PubMed DOI PMC

Parrado-Fernández C, Blennow K, Hansson M, Leoni V, Cedazo-Minguez A, Björkhem I. Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers. J Cell Mol Med. (2018) 22:5151–4. doi: 10.1111/jcmm.13767, PMID: PubMed DOI PMC

Castellazzi M, Morotti A, Tamborino C, Alessi F, Pilotto S, Baldi E, et al. . Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient. Fluids Barriers CNS. (2020) 17. doi: 10.1186/s12987-020-0173-2 PubMed DOI PMC

Sumien N, Cunningham JT, Davis DL, Engelland R, Fadeyibi O, Farmer GE, et al. . Neurodegenerative disease: roles for sex, hormones, and oxidative stress. Endocrinology. (2021) 162:1–14. doi: 10.1210/endocr/bqab185 PubMed DOI PMC

de Lange AMG, Barth C, Kaufmann T, Maximov II, van der Meer D, Agartz I, et al. . Women’s brain aging: effects of sex-hormone exposure, pregnancies, and genetic risk for Alzheimer’s disease. Hum Brain Mapp. (2020) 41:5141–50. doi: 10.1002/hbm.25180, PMID: PubMed DOI PMC

Coales I, Tsartsalis S, Fancy N, Weinert M, Clode D, Owen D, et al. . Alzheimer’s disease-related transcriptional sex differences in myeloid cells. J Neuroinflammation. (2022) 19:247–13. doi: 10.1186/s12974-022-02604-w, PMID: PubMed DOI PMC

Califf RM. Biomarker definitions and their applications. Exp Biol Med. (2018) 243:213–21. doi: 10.1177/1535370217750088, PMID: PubMed DOI PMC

Tadayon E, Moret B, Sprugnoli G, Monti L, Pascual-Leone A, Santarnecchi E. Improving choroid plexus segmentation in the healthy and diseased brain: relevance for tau-PET imaging in dementia. J Alzheimers Dis. (2020) 74:1057–68. doi: 10.3233/JAD-190706, PMID: PubMed DOI PMC

Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond